Sa1751 - A Phase 3 Study of Vedolizumab for Induction and Maintenance Therapy in Japanese Patients with Moderately to Severely Active Ulcerative Colitis

2018 ◽  
Vol 154 (6) ◽  
pp. S-380-S-381
Author(s):  
Mamoru Watanabe ◽  
Satoshi Motoya ◽  
Kenji Watanabe ◽  
Haruhiko Ogata ◽  
Takanori Kanai ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Maintenance Therapy ◽  
Japanese Patients ◽  
Active Ulcerative Colitis ◽  
Phase 3

scholarly journals Tofacitinib as Induction and Maintenance Therapy in Japanese Patients with Active Ulcerative Colitis

2019 ◽  
Vol 4 (4) ◽  
pp. 131-143 ◽  
Author(s):  
Yasuo Suzuki ◽  
Mamoru Watanabe ◽  
Toshiyuki Matsui ◽  
Satoshi Motoya ◽  
Tadakazu Hisamatsu ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Maintenance Therapy ◽  
Japanese Patients ◽  
Active Ulcerative Colitis

Fr531 EFFICACY AND SAFETY OF FILGOTINIB AS MAINTENANCE THERAPY FOR PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 2B/3 SELECTION STUDY

2021 ◽  
Vol 160 (6) ◽  
pp. S-350
Author(s):  
Laurent Peyrin-Biroulet ◽  
Edward V. Loftus ◽  
Silvio Danese ◽  
Séverine Vermeire ◽  
William J. Sandborn ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Maintenance Therapy ◽  
Active Ulcerative Colitis ◽  
Efficacy And Safety

scholarly journals Erratum to: Four-year maintenance treatment with adalimumab in Japanese patients with moderately to severely active ulcerative colitis

2017 ◽  
Vol 52 (9) ◽  
pp. 1079-1079
Author(s):  
Yasuo Suzuki ◽  
Satoshi Motoya ◽  
Hiroyuki Hanai ◽  
Toshifumi Hibi ◽  
Shiro Nakamura ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Maintenance Treatment ◽  
Japanese Patients ◽  
Active Ulcerative Colitis
Sign in / Sign up

Export Citation Format

Share Document